Report Feature
The future of the cancer/tumor profiling market looks promising with opportunities in the clinical applications and research applications industries. The global cancer/tumor profiling market is expected to grow with a CAGR of 11% from 2019 to 2024. The major growth drivers for this market are growing demand for cancer profiling method by oncologists to diagnose cancers, rise in adoption of cancer biomarkers for tumor profiling, increasing utility of biomarkers in tumor profiling, increasing cancer patients across the globe, and growth in use of next-generation sequencing technique for cancer profiling.
A report of more than 150 pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of cancer/tumor profiling market report download the report brochure.
The study includes the cancer/tumor profiling market size and forecast for the global cancer/tumor profiling market through 2024, segmented by application, technology, cancer type, biomarker type, and region as follows:
By Application [$M shipment analysis for 2013 – 2024]:
- Clinical Applications
- Research Applications
By Technology [$M shipment analysis for 2013 – 2024]:
- Immunoassays
- Hybridization
- Next-generation Sequencing
- Mass Spectroscopy
- Other Technologies
By Cancer Type [$M shipment analysis for 2013 – 2024]:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma Cancer
- Other Cancer Types
By Biomarker Type[$M shipment analysis for 2013 – 2024]:
- Genetic Biomarkers
- Protein Biomarkers
- Other Biomarkers
By Region [$M shipment analysis for 2013 – 2024]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Rest of the World
- Brazil
Some of the cancer/tumor profiling companies profiled in this report include Illumina, Qiagen, HTG Molecular Diagnostics, Genomic Health, Caris Life Sciences, Helomics, Nanostring Technologies, Oxford Gene Technology, and Ribomed Biotechnologies.
Some of the features of this report:
- Market size estimates: Global cancer/tumor profiling market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis: Global market size by application, technology, cancer type, biomarker type, and region.
- Regional analysis: Global cancer/tumor profiling market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities: Analysis on growth opportunities in different applications and regions for cancer/tumor profiling in the global cancer/tumor profiling market.
- Strategic analysis: This includes M&A, new product development, and competitive landscape for, cancer/tumor profiling in the global cancer/tumor profiling market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Table of Contents
1. Executive Summary
6.2 Emerging Trends in Global Cancer/Tumor Profiling Market
4.1 Global Cancer/Tumor Profiling Market by Region
4.2.1 Market by Application: Clinical Applications and Research Applications
4.2.2 Market by Technology: Immunoassays, Hybridization, Next-generation Sequencing, Mass Spectroscopy, and Other Technologies
4.2.3 Market by Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer Types
4.2.4 Market by Biomarker Type: Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers
4.3.1 Market by Application: Clinical Applications and Research Applications
4.3.2 Market by Technology: Immunoassays, Hybridization, Next-generation Sequencing, Mass Spectroscopy, and Other Technologies
4.3.3 Market by Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer Types
4.3.4 Market by Biomarker Type: Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers
4.4.1 Market by Application: Clinical Applications and Research Applications
4.4.2 Market by Technology: Immunoassays, Hybridization, Next-generation Sequencing, Mass Spectroscopy, and Other Technologies
4.4.3 Market by Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer Types
4.4.4 Market by Biomarker Type: Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers
4.5.1 Market by Application: Clinical Applications and Research Applications
4.5.2 Market by Technology: Immunoassays, Hybridization, Next-generation Sequencing, Mass Spectroscopy, and Other Technologies
4.5.3 Market by Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer Types
4.5.4 Market by Biomarker Type: Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers
6.1.1 Growth Opportunities for Global Cancer/Tumor Profiling Market by Application
6.1.2 Growth Opportunities for Global Cancer/Tumor Profiling Market by Technology
6.1.3 Growth Opportunities for Global Cancer/Tumor Profiling Market by Cancer Type
6.1.4 Growth Opportunities for Global Cancer/Tumor Profiling Market by Biomarker Type
6.1.5 Growth Opportunities for Global Cancer/Tumor Profiling Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising potential, high-growth opportunities for the global cancer/tumor profiling market by application (clinical applications and research applications), technology (immunoassays, hybridization, next-generation sequencing, mass spectroscopy, and other technologies (pyrosequencing and sanger sequencing), cancer type (breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma cancer, and other cancer types (non-hodgkin’s lymphoma, melanoma, leukemia, thyroid, bladder, and kidney)), biomarker type (genetic biomarkers, protein biomarkers, and other biomarkers), and region (North America, Europe, Asia-Pacific, and ROW)?
- • Which segments will grow at a faster pace and why?
- • Which regions will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the drivers and challenges of the cancer/tumor profiling market?
- • What are the business risks and threats to the cancer/tumor profiling market?
- • What are emerging trends in this cancer/tumor profiling market and the reasons behind them?
- • What are some changing demands of customers in the cancer/tumor profiling market?
- • What are the new developments in the cancer/tumor profiling market? Which companies are leading these developments?
- • Who are the major players in this cancer/tumor profiling market? What strategic initiatives are being implemented by key players for business growth?
- • What are some of the competitive products and processes in this cancer/tumor profiling area and how big of a threat do they pose for loss of market share via material or product substitution?
- • What M & A activities have taken place in the last 5 years in cancer/tumor profiling market?
